110 related articles for article (PubMed ID: 25950813)
1. RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
Toledo RA; Maciel RM; Erlic Z; Lourenço DM; Cerutti JM; Eng C; Neumann HP; Toledo SP
Thyroid; 2015 Aug; 25(8):973-4. PubMed ID: 25950813
[No Abstract] [Full Text] [Related]
2. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
[TBL] [Abstract][Full Text] [Related]
3. C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective.
Baloch ZW; LiVolsi VA
Turk Patoloji Derg; 2015; 31 Suppl 1():60-79. PubMed ID: 26177318
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
[TBL] [Abstract][Full Text] [Related]
5. Different outcomes in sporadic versus familial medullary thyroid cancer.
Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
[TBL] [Abstract][Full Text] [Related]
7. Use of Dexmedetomidine in a Parturient With Multiple Endocrine Neoplasia Type 2A Undergoing Adrenalectomy and Thyroidectomy: A Case Report.
Faulkner AL; Swanson E; McLarney TL; Lee CY; Rebel A
A A Pract; 2019 Mar; 12(5):136-140. PubMed ID: 30095445
[TBL] [Abstract][Full Text] [Related]
8. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
9. Management of medullary carcinoma of the thyroid during pregnancy in a patient with an intron substitution.
Walshe P; Seaberg RM; Yehuda M; Freeman J
J Otolaryngol Head Neck Surg; 2008 Apr; 37(2):E39-41. PubMed ID: 19137655
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.
Boikos SA; Stratakis CA
Histol Histopathol; 2008 Jan; 23(1):109-16. PubMed ID: 17952863
[TBL] [Abstract][Full Text] [Related]
11. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
12. [Medullary thyroid cancer - the present state of art].
Krysiak R; Marek B; Okopień B
Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
[TBL] [Abstract][Full Text] [Related]
13. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
[TBL] [Abstract][Full Text] [Related]
16. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
Krampitz GW; Norton JA
Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
[TBL] [Abstract][Full Text] [Related]
17. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
18. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
[TBL] [Abstract][Full Text] [Related]
20. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
